My Ovarian Cancer tumor markers are rising — what does this mean

Understanding Rising Ovarian Cancer Tumor Markers

I understand this is concerning news. Let me help you understand what rising tumor markers mean and what questions to ask your care team.

What Tumor Markers Tell Us

Tumor markers are proteins or substances produced by cancer cells (or by your body in response to cancer). For ovarian cancer, the most commonly monitored markers are:

CA-125 - This is the primary marker used for ovarian cancer monitoring. According to NCCN Guidelines, CA-125 levels tend to correlate with disease course, especially in patients with elevated pretreatment levels. It can be useful for:

• Monitoring response to therapy
• Detecting recurrence during surveillance
• Assessing disease extent

HE4 (Human Epididymis Protein 4) - Some evidence suggests HE4 may be useful as a prognostic marker, decreases during treatment response, and may help with early detection of recurrence. However, NCCN Guidelines note that results vary across studies, so it's not routinely recommended for all patients.

What Rising Markers Generally Indicate

When tumor markers rise, this may suggest (but doesn't definitively prove):

• Cancer cells are growing or becoming more active
• The cancer may be progressing or recurring
• Your current treatment may not be working as effectively as hoped

Important context: Rising markers don't automatically mean your situation is hopeless. The clinical picture is much more complex—your imaging, symptoms, and overall health status matter significantly.

The Clinical Framework: How Doctors Think About This

According to NCCN Guidelines, oncologists evaluate rising markers by considering:

1. The rate of rise - How quickly are they increasing?
2. Your baseline levels - Were they elevated before treatment?
3. The pattern - Is this a steady increase or fluctuation?
4. Imaging findings - Do scans show actual tumor growth?
5. Your symptoms - Are you experiencing new or worsening symptoms?
6. Treatment response - How have you responded to prior therapies?

A single elevated marker result is less concerning than a consistent upward trend. Your doctor will look at the whole picture, not just one number.

Questions to Ask Your Oncologist

These questions will help you understand YOUR specific situation:

1. "How much have my markers risen, and over what time period?" - This helps you understand the rate of change, which matters more than the absolute number.

2. "What do my imaging studies (CT, PET, ultrasound) show right now?" - Imaging is often more reliable than markers alone for detecting actual tumor growth.

3. "Could anything else besides cancer progression explain this rise?" - Benign conditions, inflammation, or other factors can sometimes elevate markers.

4. "What are my treatment options at this point?" - This opens discussion about next steps, whether that's continuing current treatment, switching approaches, or clinical trials.

5. "How soon do we need to make a decision, and what would you recommend?" - Understanding the timeline and your doctor's clinical reasoning is important.

6. "Are there any biomarker tests (like BRCA status, HRD testing, or other molecular markers) that might guide treatment decisions?" - These can help identify targeted therapy options.

What Happens Next

Your oncologist will likely recommend one or more of these steps:

• Repeat imaging to see if there's actual tumor growth
• Repeat marker testing to confirm the trend
• Discussion of treatment options - which might include continuing current therapy, switching to a different approach, or exploring clinical trials
• Possible biopsy or tissue testing if needed to understand the cancer's characteristics

Important Reminders

Rising markers are a signal that warrants attention and discussion with your care team, but they're not a final verdict. Treatment decisions should be based on your complete clinical picture—not markers alone.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

---

Sources cited:

• NCCN Guidelines for Ovarian Cancer (Version 3.2025) - Tumor marker monitoring and clinical interpretation
• American Cancer Society resources on ovarian cancer markers

Would you like me to help you understand any specific marker values, or do you have other questions about your results?